Science
Research
Projects
Publications
News
Team
Explorables
Contact
modelling
Modeling the impact of the Omicron infection wave in Germany
B F Maier
,
A Burdinski
,
M Wiedermann
,
A H Rose
,
Matthias an der Heiden
,
Ole Wichmann
,
Thomas Harder
,
F Schlosser
,
D Brockmann
medRxiv: https://www.medrxiv.org/content/10.1101/2022.07.07.22277391v1
In November 2021, the first case of SARS-CoV-2 “variant of concern” (VOC) B.1.1.529 (“Omicron”) was reported in Germany, alongside global reports of …
PDF
View
New Preprint Out: Modeling the impact of the Omicron infection wave in Germany
B F Maier
,
A Burdinski
,
M Wiedermann
,
A H Rose
,
Matthias an der Heiden
,
Ole Wichmann
,
Thomas Harder
,
F Schlosser
,
D Brockmann
Estimating the distribution of COVID-19-susceptible, -recovered, and -vaccinated individuals in Germany up to April 2022
B F Maier
,
A H Rose
,
A Burdinski
,
P Klamser
,
Hannelore Neuhauser
,
Ole Wichmann
,
Lars Schaade
,
Lothar H. Wieler
,
D Brockmann
https://www.medrxiv.org/content/10.1101/2022.04.19.22274030v1
After having affected the population for two years, the COVID-19 pandemic has reached a phase where a considerable number of people in Germany have …
PDF
DOI
View
Abschätzung der Infektionswelle durch die SARS-CoV-2 VOC Omikron
B F Maier
,
A Burdinski
,
M Wiedermann
,
Matthias an der Heiden
,
Thomas Harder
,
F Schlosser
,
D Brockmann
Bericht (German)
Wir modellieren mögliche Verläufe einer durch die SARS-CoV-2 “variant of concern” (VOC)
B.1.1.529
(
“Omikron”
) verursachten Infektionswelle in …
PDF
Preprint out: Digital contact tracing contributes little to COVID-19 outbreak containment
A Burdinski
,
D Brockmann
,
B F Maier
Digital contact tracing contributes little to COVID-19 outbreak containment
A Burdinski
,
D Brockmann
,
B F Maier
https://www.medrxiv.org/content/10.1101/2021.06.21.21259258v1
Digital contact tracing applications have been introduced in many countries to aid in the containment of COVID-19 outbreaks. Initially, enthusiasm was …
PDF
Cite
DOI
View
Preprint out: Potential benefits of delaying the second mRNA COVID-19 vaccine dose
B F Maier
,
A Burdinski
,
A H Rose
,
F Schlosser
,
D Hinrichs
,
C Betsch
,
L Korn
,
P Sprengholz
,
M Meyer-Hermann
,
T Mitra
,
K Lauterbach
,
D Brockmann
«
Cite
×